Brock Metcalf
Fondateur chez Reference Capital Management LLC
Profil
Brock Metcalf was the founder of Oregon Life Sciences LLC, which was founded in 1994, where he held the title of Managing Director.
He is also the founder of Reference Capital Management LLC, which was founded in 2006, where he holds the title of Managing Partner.
Dr. Metcalf's current job(s) include being the Chief Executive Officer & Director at Artielle ImmunoTherapeutics, Inc. and a Director at Virogenomics BioDevelopment, Inc.Dr. Metcalf's former job(s) include being a Partner at Cascadia Pacific Management LLC, a Board Member at GRAYL, Inc. from 2014 to 2015, a Principal at EPISTAT, Inc., and a Trustee at The OGI School of Science & Engineering.
Dr. Metcalf's education history includes a graduate degree from San Francisco State University, an undergraduate degree from the University of California, Berkeley, and a doctorate degree from Virginia Polytechnic Institute & State University, which was conferred in 1990.
Postes actifs de Brock Metcalf
| Sociétés | Poste | Début |
|---|---|---|
Reference Capital Management LLC
 Reference Capital Management LLC Investment ManagersFinance Reference Capital Management LLC (Reference Capital) is a venture capital firm founded in 2006 by Wayne L. Embree and Brock Metcalf. The firm is headquartered in Portland, Oregon. | Fondateur | 01/01/2006 |
Virogenomics BioDevelopment, Inc.
 Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | Directeur/Membre du Conseil | - |
Artielle ImmunoTherapeutics, Inc.
 Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Directeur Général | - |
Anciens postes connus de Brock Metcalf
| Sociétés | Poste | Fin |
|---|---|---|
GRAYL, Inc.
 GRAYL, Inc. Containers/PackagingProcess Industries GRAYL, Inc. provides consumer goods. The firm specializes in water filtration and water purification. The company was founded by Nancie Weston and Merrigan Travis in 2012 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | 01/01/2015 |
| The OGI School of Science & Engineering | Directeur/Membre du Conseil | - |
Cascadia Pacific Management LLC
 Cascadia Pacific Management LLC Investment ManagersFinance Founded in 1994, Cascadia Pacific Management LLC is a privately-owned investment fund management company located in Portland, Oregon | Private Equity Investor | - |
| EPISTAT, Inc. | Private Equity Investor | - |
Oregon Life Sciences LLC
 Oregon Life Sciences LLC Investment ManagersFinance Oregon Life Sciences LLC (Oregon Life Sciences) is a venture capital firm founded in 1994 by James Korfhage and John Metcalf. The firm is headquartered in Eugene, Oregon. | Fondateur | - |
Formation de Brock Metcalf
| San Francisco State University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
| Virginia Polytechnic Institute & State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Cascadia Pacific Management LLC
Cascadia Pacific Management LLC Investment ManagersFinance Founded in 1994, Cascadia Pacific Management LLC is a privately-owned investment fund management company located in Portland, Oregon | Finance |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | Health Technology |
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Health Technology |
GRAYL, Inc.
GRAYL, Inc. Containers/PackagingProcess Industries GRAYL, Inc. provides consumer goods. The firm specializes in water filtration and water purification. The company was founded by Nancie Weston and Merrigan Travis in 2012 and is headquartered in Seattle, WA. | Process Industries |
Oregon Life Sciences LLC
Oregon Life Sciences LLC Investment ManagersFinance Oregon Life Sciences LLC (Oregon Life Sciences) is a venture capital firm founded in 1994 by James Korfhage and John Metcalf. The firm is headquartered in Eugene, Oregon. | Finance |
| EPISTAT, Inc. | |
Reference Capital Management LLC
Reference Capital Management LLC Investment ManagersFinance Reference Capital Management LLC (Reference Capital) is a venture capital firm founded in 2006 by Wayne L. Embree and Brock Metcalf. The firm is headquartered in Portland, Oregon. | Finance |
